Best Pharma Strategies from the Experts

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

At one point in his career, I Don’t Care Host Kevin Stevenson spent some time on the pharma side of things, in between working at hospitals.

Today he dives back into that world with Donovan Quill, President, and CEO at Optime Care, a nationally recognized pharmacy, distribution, and patient management organization that creates the trusted path to a fulfilled life for patients with rare and orphan disorders.

“What we try to do is create a holistic program for those patients where we combine all the services you would see in a pharmacy in a patient care model,” Quill said. “We try to create a one-stop-shop for patients to really get the care they need from a support standpoint, from affordability, and also to distribute their products to them in their home or site of care.”

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand.” – Donovan Quill

Orphan disorders and drugs are a bit different from regular pharmaceuticals. Typically, an orphan drug is a treatment for a condition with less than 200,000 patients in the U.S., according to the FDA definition. But, what they do at Optime Care is treat disorders that are even more rare, or “Ultra orphan,” according to Quill.

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand,” Quill said. “We really try to focus on the patients who need a little extra care.”

Most of the time, the patients they treat have a disorder they’ve never heard of and are treated with a product they can’t pronounce, Quill said jokingly.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

control panels
The Unsung Heroes of Data Centers: Industrial Control Panels
April 8, 2026

In the high-tech world of data centers—where petabytes of data flow every second and uptime is measured in milliseconds—there’s a quiet, powerful force working behind the scenes: industrial control panels. While servers and switches often steal the spotlight, control panels are the backbone that keeps the entire facility running safely, efficiently, and reliably. Powering the…

Read More
powder
Liquid vs. Powder Coating: Which Finishing System is Right for Your Operation?
April 8, 2026

Liquid paint systems or Powder paint systems? When you’re looking to upgrade or automate your finishing system, the “Liquid vs. Powder” debate is usually the first hurdle. If you’re currently running manual lines for both, or considering a move from liquid to powder, the choice can feel like a trade-off between efficiency and flexibility. As…

Read More
Albers
Albers Testimonial
April 8, 2026

Virtually No Downtime   Albers Finishing & Solutions is a family-owned and operated company in Cheney, Kansas. The company specializes in processing parts by liquid painting, plating or anodizing to solve their customers finishing needs. The company’s origins began with an opportunity to deliver finished pieces to a business partner, which meant they’d need a…

Read More
Prince Manufacturing Elevates Finishing with IntelliFinishing System
April 8, 2026

For more than five years, Prince Manufacturing – a maker of hydraulic cylinders, valves and pumps founded in 1941 and serving a wide variety of markets with four facilities across three states – has leveraged an IntelliFinishing fully automated liquid paint system to bring new efficiencies to its operation. This system helps Prince uphold the…

Read More